Evaluating the Efficacy of a Novel Oral Supplement in Tackling Malnutrition in the Elderly

NCT ID: NCT02683720

Last Updated: 2016-07-21

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

82 participants

Study Classification

INTERVENTIONAL

Study Start Date

2016-07-31

Study Completion Date

2017-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

ProMO aims to investigate the effectiveness of a newly developed ONS in increasing body weight, muscle mass and function in malnourished elderly compared to standard care.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Malnutrition Muscle Health

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

ONS1

new product

Group Type EXPERIMENTAL

ONS

Intervention Type DIETARY_SUPPLEMENT

randomized clinical trial involving different ONS strategies

ONS2

usual care

Group Type ACTIVE_COMPARATOR

ONS

Intervention Type DIETARY_SUPPLEMENT

randomized clinical trial involving different ONS strategies

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

ONS

randomized clinical trial involving different ONS strategies

Intervention Type DIETARY_SUPPLEMENT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* age 65+
* at risk of malnutrition/ malnourished

Exclusion Criteria

* • Mental status that is incompatible with the proper conduct of the study

* Illness of such severity that life expectancy is considered to be less than 12 months
* Use of diabetes medication (e.g. insulin, methformin)
* Use of an oral nutritional supplement in the previous three months
* Participating in any regular exercise training program (≥2h/w)
* Renal insufficiency (eGFR \<30 mL/min/1.73 m2)
* Unstable organ failure or organ failure necessitating a special diet
* Chronic corticosteroids use
* Recent (previous 2 months) use of antibiotics
* Recent (previous 3 months) change in habitual medication use (e.g statins and thyroxin)
* Recent blood donation (\<1 month prior to Day 01 of the study)
* Not willing or afraid to give blood during the study
* Allergic or sensitive for milk proteins
* Reported vegan or macrobiotic life-style
* Drug and/or alcohol abuse (current consumption of more than 21 alcoholic drinks per week)
* Individual unable to give informed consent
* Current participation in other research from the Division of Human Nutrition
* Not having a general practitioner
* Personnel of Wageningen University, department of Human Nutrition, their partner and their first and second degree relatives
Minimum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Vitalnext

UNKNOWN

Sponsor Role collaborator

Wageningen University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Lisette de Groot

MSc PhD Prof

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Wageningen University

Wageningen, , Netherlands

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Netherlands

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Pol Grootswagers, Msc

Role: primary

References

Explore related publications, articles, or registry entries linked to this study.

Grootswagers P, Smeets E, Oteng AB, Groot L. A novel oral nutritional supplement improves gait speed and mitochondrial functioning compared to standard care in older adults with (or at risk of) undernutrition: results from a randomized controlled trial. Aging (Albany NY). 2021 Apr 2;13(7):9398-9418. doi: 10.18632/aging.202912. Epub 2021 Apr 2.

Reference Type DERIVED
PMID: 33799307 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

NL56873.081.16

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Optimal Feeding for NET Patients
NCT02481804 COMPLETED NA